07/28/2026
🧠Sandip is an experienced advocate before the PTAB who regularly handles inter partes reviews, re-examinations and related appellate issues.
Partner Sandip Patel was highlighted in IAM’s 2026 Patent 1000 for his experience and versatility in patent law and IP litigation, as well as his role in the groundbreaking CureVac biotechnology resolution last fall.
IAM subscribers can read the firm’s full profile in the guide here: https://bit.ly/4yIy1ts